Related Experiment Video
Updated: Jul 18, 2026
10:15
Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
Published on: March 22, 2017
6.9K
Bioengineering Innervated Esophagus With Improved Motility: Limitations and Future Directions
Heather Wanczyk1, Joanne Walker1, Allan M Goldstein2
1Department of Pediatrics, University of Connecticut Health Center, Farmington, Connecticut, USA.
Neurogastroenterology and Motility
|May 16, 2025
Summary
Bioengineered esophageal tissues show promise but lack innervation for motility. Innovations in 3D bioprinting, electrospinning, and AI are key to developing functional esophageal replacements with restored gut function.
Area of Science:
- Regenerative Medicine
- Biomaterials Science
- Gastroenterology
Background:
- Esophageal tissue engineering has advanced using biomaterials and stem cells.
- Current limitations include the lack of innervation and peristalsis in engineered tissues.
- No stem cell therapies or esophageal substitutes currently restore esophageal motility.
Purpose of the Study:
- Review advances and limitations in assessing esophageal motility in bioengineered tissues.
- Highlight innovative technologies like 3D bioprinting, electrospinning, and AI for gut innervation.
- Discuss future directions for patient-specific esophageal implants and equitable access.
Main Methods:
- Literature review of current research in esophageal tissue engineering.
- Analysis of assessment metrics for esophageal motility.
- Exploration of emerging technologies and neuronal cellular approaches.
Main Results:
- Significant progress in biomaterials and stem cell integration for tissue structure and function.
- Identified a critical gap in achieving functional innervation and peristalsis.
- Highlighted the potential of 3D bioprinting, electrospinning, and AI in addressing this gap.
Conclusions:
- Achieving functional innervation is crucial for restoring esophageal motility in bioengineered replacements.
- Innovative technologies offer promising avenues for developing clinically viable esophageal therapies.
- Patient-specific implants and equitable access are vital for future clinical translation.
Related Concept Videos
01:20Gastrointestinal Motility Disorders
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
01:24Esophagus
The esophagus, a muscular conduit linking the pharynx and stomach, measures roughly 10 inches (25.4 cm) and sits behind the trachea. It remains collapsed when not swallowing. The esophagus follows a predominantly straight path through the thoracic mediastinum and enters the abdominal cavity through a diaphragmatic opening known as the esophageal hiatus.
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...
01:16Gastric Motility
Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
01:21Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
01:26Esophageal Strictures-II: Clinical Features and Management
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
01:27Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...